Cargando…
Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711512/ http://dx.doi.org/10.1016/j.jemermed.2022.10.026 |
| _version_ | 1784841593309626368 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9711512 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97115122022-12-01 Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263 J Emerg Med Article Published by Elsevier Inc. 2022-10 2022-11-30 /pmc/articles/PMC9711512/ http://dx.doi.org/10.1016/j.jemermed.2022.10.026 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263 |
| title | Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263 |
| title_full | Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263 |
| title_fullStr | Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263 |
| title_full_unstemmed | Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263 |
| title_short | Therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicenter, randomized, controlled trial Lopes RD, Melo de Barros e Silva PG, Furtado RM, et. al Lancet. 2021; 297: 2253-2263 |
| title_sort | therapeutic versus prophylactic anticoagulation for patients admitted to the hospital with covid-19 and elevated d-dimer concentration (action): an open-label, multicenter, randomized, controlled trial lopes rd, melo de barros e silva pg, furtado rm, et. al lancet. 2021; 297: 2253-2263 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711512/ http://dx.doi.org/10.1016/j.jemermed.2022.10.026 |